MedImmune to Present Nine Abstracts on RSV and Influenza at 48th Annual...
WASHINGTON, Oct. 24 /PRNewswire-USNewswire/ — MedImmune announced today it will present nine abstracts at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/46th...
View ArticleMedImmune Submits Marketing Authorisation Application in European Union for...
MedImmune Submits Marketing Authorisation Application in European Union for Intranasal Vaccine to Prevent Seasonal Influenza NIJMEGEN, The Netherlands, January 6, 2009 — MedImmune, the global biologics...
View ArticlePOSITION ON BIOSIMILARS
MedImmune supports the establishment of a regulatory pathway for the approval of biosimilars in the U.S. that ensures patient safety, product efficacy and continued incentives for biotechnology...
View Article
More Pages to Explore .....
